相关实验视频
Updated: Sep 11, 2025

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
链接瘤血管生成和瘤免疫力
Ashraf Ul Kabir1,2, Madhav Subramanian1,3, Yoojung Kwon1
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
免疫检查点阻塞疗法对癌症治疗有希望,但许多患者没有反应. 了解瘤血管生成及其与免疫反应的联系,对于提高免疫疗法的疗效至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 免疫检查点阻塞 (ICB) 疗法改变了癌症治疗,但响应率仍然有限.
- 与瘤相关的血管异常阻碍了免疫细胞的透,并创造了一个免疫抑制的瘤微环境.
- 瘤血管生成和抗瘤免疫活性之间存在反向相关性.
研究的目的:
- 审查瘤血管生成在瘤免疫中的作用及其对免疫治疗结果的影响.
- 探索控制血管生成和瘤免疫之间的相互作用的分子机制.
- 讨论癌症治疗中组合治疗的新型抗血管生成策略.
主要方法:
- 综合临床前和临床研究的文献综述.
- 血管新生-免疫交叉的分子机制的分析.
- 讨论新兴的抗血管性调节剂.
主要成果:
- 瘤血管生成显著影响瘤的进展和对免疫治疗的反应.
- 功能障碍的瘤血管系统损害了抗癌免疫反应的有效性.
- 新兴的抗血管原剂显示出增强免疫疗法的潜力.
结论:
- 向瘤血管生成是一种有前途的策略,可以克服对免疫检查点阻塞的抵抗力.
- 涉及抗血管原剂和免疫疗法的组合疗法可能会改善患者的治疗结果.
- 需要进一步的研究,以优化结合治疗方法,以改善癌症治疗.
更多相关视频
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
相关概念视频
The Tumor Microenvironment
Mechanism of Angiogenesis
Tumor Immunotherapy
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...